NeuroSearch finds some optimism

Following the failure of two major deals in 1999, with Bristol-Myers Squibb Co. and Pharmacia & Upjohn, the future of NeuroSearch A/S looked bleak. However, with products advancing through its pipeline and a fresh deal with Abbott Laboratories, NeuroSearch (CSE:NEUS) appears to have emerged from the

Read the full 468 word article

How to gain access

Continue reading with a
two-week free trial.